Web Results

caselaw.findlaw.com/us-supreme-court/09-152.html

United States Supreme Court. BRUESEWITZ ET AL. v. WYETH LLC, FKA WYETH, INC., ET AL., (2011). No. 09-152. Argued: October 12, 2010 Decided: February 22, 2011. The National Childhood Vaccine Injury Act of 1986 (NCVIA or Act) created a no-fault compensation program to stabilize a vaccine market adversely ...

www.wlf.org/litigating/case_detail.asp?id=630

On February 22, 2011, the U. S. Supreme Court held that a federal law expressly preempts all state-law products liability suits challenging the design of widely administered childhood vaccines, which the Food and Drug Administration (FDA) has already determined to be safe and effective. The decision was a victory for the ...

www.oyez.org/cases/2010/09-152

Oct 12, 2010 ... Bruesewitz v. Wyeth Inc. ... Respondent. Wyeth, Inc., fka Wyeth Laboratories, et al . ... defective design. A federal judge dismissed the lawsuit, ruling that the National Childhood Vaccine Injury Act protected Wyeth from lawsuits over vaccine injury claims. The U.S. Court of Appeals for the 3rd Circuit affirmed.

www.mwe.com/en/thought-leadership/newsletters/2015/10/anda-update-october-2015

Amgen Inc., v. Sandoz Inc., 2015 WL 4430108, Case No. 2015-1499 (Fed. Cir. July 21, 2015), (Lourie, J.) (Newman, J., concurring in part and dissenting in part) ...... Weeks v. Wyeth, Inc., et al., 2015 WL 4635176 (M.D. Ala. Aug. 3, 2015) (J. Watkins, D.J.). This case involves metoclopramide (MCP), the generic counterpart of ...

www.kirkland.com/sitecontent.cfm?contentid=220&itemid=8017

Professional Profile. Doug Smith has litigated cases at both the trial and appellate stage in state and federal courts throughout the country, including commercial, mass tort, product liability, securities, bankruptcy, environmental, and intellectual property cases. He is a member of the American Law Institute and has published ...

onlinelibrary.wiley.com/doi/10.1002/cncr.24236/full

Apr 28, 2009 ... In an analysis by Bui et al, CAIX expression in ≫85% of tumor cells (high CAIX expression) has been associated with improved survival and a higher .... The program was made possible by educational grants provided by Genentech, Novartis Pharmaceuticals, Pfizer, Inc, and Wyeth Pharmaceuticals.

www.contractormisconduct.org/misconduct

Dell, Inc. $1,750,000. 9/28/2007, Violations of Classified Information Security Requirements at Los Alamos National Laboratory University of California, $2,800,000. 9/28/2007, Insider Trading Dell, Inc. $358,566. 9/28/2006, Waldbuesser et al v. Northrop Grumman (ERISA Violations) Northrop Grumman, $16,750,000. 9/28/ ...

www.ippractice.ca/litigation-statistics/intellectual-property-proceedings-in-federal-court-for-2016

T-72-16, QUALCOMM INCORPORATED v. COMMISSIONER OF PATENTS, Patent – Correction of Register, 2016-01-13, Smart & Biggar. T-79-16, UNDER ARMOUR, INC. v. DISTRIBUTION ONDECKDEALS INC. ET AL. Trade Mark Infringement, 2016-01-14, GOWLING LAFLEUR HENDERSON LLP; STEINBERG , JANE;.

www.ncbi.nlm.nih.gov/pmc/articles/PMC1855532

Feb 5, 2007 ... The susceptibility trends for the species of the Bacteroides fragilis group against various antibiotics from 1997 to 2004 were determined by using data for 5,225 isolates referred by 10 medical centers. The antibiotic test panel included ertapenem, imipenem, meropenem, ampicillin-sulbactam, ...